Genetics for Healthcare
Claim This Podcastby Rome Madison
Podcast Authority
Beta
Podcast Overview
<p>This is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcare</p>
Language
🇺🇲
Publishing Since
3/10/2025
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
BetaRecommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
Reach the team behind Genetics for Healthcare
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
June 12, 2026
Insomnia, Depression and the Gene That Changed Everything: How PGx Testing Ended Decades of Misdiagnosis
<p>For decades, Mariela Ayala lived under the weight of misdiagnosis—insomnia, depression, recurring infections, medication side effects, and steady weight gain. As prescriptions stacked up (25 at one point), she kept pushing, studying, and showing up for life. But everything changed when a perceptive psychiatrist ordered pharmacogenomic testing. </p><p>The results: an inherited MTHFR gene variant impacting folate activation which helps control many bodily functions like our metabolism, muscle structure and energy. With that insight, her team introduced methylated B12 and folate, a careful 90-day taper off unnecessary meds, and a return to real, culturally rich foods and herbs. Within weeks she felt energy and clarity return; blood pressure normalized; weight began to fall—ultimately 200 pounds lost holistically. </p><p>Today, Mariela is “Mari with the 411,” coaching high performers to rebuild identity and standards without abandoning culture. Her story is a rallying cry for patient advocacy, clinician awareness of PGx, and the power of precision medicine to change lives now—not someday.</p><p>Key takeaways </p><ul><li>Advocate for yourself: ask about pharmacogenomic testing and second opinions.</li><li>Right form matters: methylated B vitamins and whole, culturally rooted foods supported Mariela’s turnaround.</li><li>PGx testing can flag meds to avoid and guide safer, more effective care.</li></ul><p><strong>META DESCRIPTION</strong></p><p>Meet Mariela Ayala, who spent 23 years treated for depression and insomnia but never felt well. A perceptive psychologist ordered a pharmacogenomic test and found an MTHFR variant that made it hard for her body to use folate. With answers at last, her plan shifted to methylated B12 and folate, a safe taper off 25 prescriptions, and fresh, flavorful foods from her culture. Within weeks her energy grew; within months her sleep, mood, blood pressure, and weight improved. Today Mariela coaches others to ask better questions, request the right tests, and build simple habits that fit real life. Her story shows how genetics can guide care, prevent years of trial-and-error, and turn fear into hope. Listen to celebrate her courage and learn how PGx can help you and your family. Genetics for Healthcare: A podcast for patients.</p>
June 5, 2026
Rare Disease = Real Community: Turning Social Media Connections Into Research Partnerships That Drive Precision Medicine Solutions
<p>In this episode Kasey Walsh explains how simple social media connections grew into formal research collaborations, a nonprofit, and a patient‑owned data platform, all motivated by her determination to help her daughter Robbie, who was born with an AP-4 hereditary spastic paraplegia (AP‑4 HSP).</p><p>She has partnered with institutions like Boston Children's Hospital, the Broad Institute, and the University of Cambridge to move AP‑4 from case reports to research action. </p><p>Kasey co‑founded Cure AP‑4 and created <a target="_blank" rel="noopener noreferrer nofollow" href="https://winsights.life/">WinSights</a> to turn caregiver stories into research data that supports precision medicine. Her work helped find biomarkers, reclassify patients once thought to have cerebral palsy, and start drug‑repurposing studies that identified existing FDA‑approved medicines that showed activity in AP‑4 models. </p><p>She candidly shares their diagnostic journey to a diagnosis, tips for working with clinicians, and how families can help shape translational research. </p><p>Listeners who face a rare disease diagnosis will learn how to turn lived experience into real‑world evidence and join a community that helps accelerate precision medicine therapies for children and adults.</p><p>Key takeaways:</p><p>- Build community: online groups can lead to treatment opportunities and practical information to make daily life better for a family managing a rare disease.</p><p>- Own your data: patient‑stewarded health information powers precision medicine studies.</p><p>- Practical steps: seek genetic testing, connect with specialty centers, and link with advocacy groups (NORD, Global Genes).</p><p></p><p><strong>META DESCRIPTION</strong></p><p>Looking for hope after a rare disease diagnosis? Hear Kasey Walsh share how her daughter Robbie inspired partnerships with Boston Children's and the University of Cambridge to find treatment for AP-4 hereditary spastic paraplegia (AP-4 HSP). Learn how social media groups became real research teams, and practical steps families can take to find community, resources, and next actions to improve care for rare diseases. We help you learn the language and build confidence to advocate for a precision medicine approach to your health and wellbeing. </p>
May 29, 2026
INEQUITY KILLS: Access Without Equal Care Drives Preventable Cancer Deaths
<p><strong>EPISODE SUMMARY</strong></p><p>Rome experienced a career high talking with Dr. Otis W. Brawley, a globally recognized Medical Oncologist and Epidemiologist at the Johns Hopkins Kimmel Cancer Center, about his work to reduce healthcare disparities. </p><p>Dr Bawley is a former Chief Medical and Scientific Officer of the American Cancer Society, and an author on the recent <a target="_blank" rel="noopener noreferrer nofollow" href="https://pubmed.ncbi.nlm.nih.gov/41400551/">Report on the Status of Disparities in the United States 2025</a>. </p><p>Rome gets to the heart of why his work has shown that people do not always get the same care inside the health system. Dr Brawley says giving people access to care is not enough. Many patients still get later diagnoses, slower follow‑up, weaker or older treatments, and fewer chances to join clinical trials. These are real, measurable differences caused by provider choices and are at the root of cancer disparities. </p><p>Key takeaways from this in-depth conversation about disparities:</p><ul><li>Care that causes disparities differs in clear ways, including delays in diagnosis and treatment inequity.</li><li>Why systemic changes to protocols and measuring clinician adherence beats simple training to deter differential treatment.</li><li>Practical solutions like patient navigation and equity metrics to reduce preventable deaths.</li></ul><p><strong>META DESCRIPTION</strong></p><p>What if a doctor’s choice—more than the cancer—decides who lives? Dr. Otis W. Brawley, a globally respected voice from the Johns Hopkins Kimmel Cancer Center, showed that black and brown patients often get worse care because doctors make different choices for them: fewer tests, slower follow‑up, less aggressive treatment, or no offer to join clinical trials. These choices come from wrong assumptions about what patients want, limits at busy or underfunded clinics, and they lead to later diagnoses and more deaths in communities of color. We need clear care rules, better tracking of who gets which treatments, and supports like patient navigation so decisions on the quality of care are fair for everyone.</p>
62 total episodes available
Deep-dive analytics for Genetics for Healthcare
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Genetics for Healthcare?
<p>This is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcare</p> - How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.